159 related articles for article (PubMed ID: 35474554)
1. Effect of clinical and histologic features on time to malignancy in 224 cases of oral leukoplakia treated by surgery.
Bagan J; Martorell M; Cebrián JL; Rubert A; Bagán L; Mezquida C; Hervás D
Clin Oral Investig; 2022 Aug; 26(8):5181-5188. PubMed ID: 35474554
[TBL] [Abstract][Full Text] [Related]
2. Malignant transformation of oral leukoplakia treated with carbon dioxide laser: a meta-analysis.
Dong Y; Chen Y; Tao Y; Hao Y; Jiang L; Dan H; Zeng X; Chen Q; Zhou Y
Lasers Med Sci; 2019 Feb; 34(1):209-221. PubMed ID: 30443884
[TBL] [Abstract][Full Text] [Related]
3. The treatment of oral leukoplakia with the CO2 laser: A retrospective study of 65 patients.
Mogedas-Vegara A; Hueto-Madrid JA; Chimenos-Küstner E; Bescós-Atín C
J Craniomaxillofac Surg; 2015 Jun; 43(5):677-81. PubMed ID: 25913630
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic factors associated with malignant transformation of oral leukoplakias: a retrospective cohort study.
Jäwert F; Pettersson H; Jagefeldt E; Holmberg E; Kjeller G; Öhman J
Int J Oral Maxillofac Surg; 2021 Nov; 50(11):1422-1428. PubMed ID: 33674140
[TBL] [Abstract][Full Text] [Related]
5. CO2 laser of oral dysplasia: clinicopathological features of recurrence and malignant transformation.
Jerjes W; Upile T; Hamdoon Z; Al-Khawalde M; Morcos M; Mosse CA; Hopper C
Lasers Med Sci; 2012 Jan; 27(1):169-79. PubMed ID: 21494890
[TBL] [Abstract][Full Text] [Related]
6. Recurrence rates after surgical removal of oral leukoplakia-A prospective longitudinal multi-centre study.
Sundberg J; Korytowska M; Holmberg E; Bratel J; Wallström M; Kjellström E; Blomgren J; Kovács A; Öhman J; Sand L; Hirsch JM; Giglio D; Kjeller G; Hasséus B
PLoS One; 2019; 14(12):e0225682. PubMed ID: 31810078
[TBL] [Abstract][Full Text] [Related]
7. Associations between clinical and histopathological characteristics in oral leukoplakia.
Evren I; Brouns ER; Poell JB; Wils LJ; Brakenhoff RH; Bloemena E; de Visscher JGAM
Oral Dis; 2023 Mar; 29(2):696-706. PubMed ID: 34601770
[TBL] [Abstract][Full Text] [Related]
8. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors.
Lee JJ; Hung HC; Cheng SJ; Chen YJ; Chiang CP; Liu BY; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):472-80. PubMed ID: 16545712
[TBL] [Abstract][Full Text] [Related]
9. Oral leukoplakia: A clinicopathological study and malignant transformation.
Tovaru S; Costache M; Perlea P; Caramida M; Totan C; Warnakulasuriya S; Parlatescu I
Oral Dis; 2023 May; 29(4):1454-1463. PubMed ID: 34982498
[TBL] [Abstract][Full Text] [Related]
10. Laser evaporation versus laser excision of oral leukoplakia: A retrospective study with long-term follow-up.
Del Corso G; Gissi DB; Tarsitano A; Costabile E; Marchetti C; Montebugnoli L; Foschini MP
J Craniomaxillofac Surg; 2015 Jul; 43(6):763-8. PubMed ID: 25979576
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathological characteristics of malignant transformation in 85 cases of oral leukoplakia].
Gao Y; Guo ZL; Luo HY; Wang J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jul; 47(7):410-3. PubMed ID: 22931571
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Different Laser-Supported Surgical Protocols for the Treatment of Oral Leukoplakia: A Long-Term Follow-Up.
Nammour S; Zeinoun T; Namour A; Vanheusden A; Vescovi P
Photomed Laser Surg; 2017 Nov; 35(11):629-638. PubMed ID: 28426376
[TBL] [Abstract][Full Text] [Related]
13. Annual malignant transformation rate of oral leukoplakia remains consistent: A long-term follow-up study.
Evren I; Brouns ER; Wils LJ; Poell JB; Peeters CFW; Brakenhoff RH; Bloemena E; de Visscher JGAM
Oral Oncol; 2020 Nov; 110():105014. PubMed ID: 33038723
[TBL] [Abstract][Full Text] [Related]
14. Clincopathological characteristics and treatment outcomes of oral leukoplakia by carbon dioxide laser excision in the elderly patients.
Yang SW; Lee YS; Chang LC; Hwang CC; Chen TA
Head Neck; 2020 May; 42(5):1014-1023. PubMed ID: 31930772
[TBL] [Abstract][Full Text] [Related]
15. Treatment of oral leukoplakia with CO2 laser (10,600 nm): analysis of 37 cases.
Campos WG; Esteves CV; Gallo CB; Domaneschi C; Aranha ACC; Lemos CA
Braz Oral Res; 2022; 36():e014. PubMed ID: 35081231
[TBL] [Abstract][Full Text] [Related]
16. Prediction of the risk of cancer and the grade of dysplasia in leukoplakia lesions using deep learning.
Ferrer-Sánchez A; Bagan J; Vila-Francés J; Magdalena-Benedito R; Bagan-Debon L
Oral Oncol; 2022 Sep; 132():105967. PubMed ID: 35763911
[TBL] [Abstract][Full Text] [Related]
17. An anatomical perspective on clinicopathological characteristics and treatment outcomes of dorsal and ventrolateral tongue leukoplakia after carbon dioxide laser surgery.
Yang SW; Lee YS; Chang LC; Yang CH; Luo CM
BMC Oral Health; 2021 Jan; 21(1):45. PubMed ID: 33509189
[TBL] [Abstract][Full Text] [Related]
18. Management of oral leukoplakia by laser surgery: relation between recurrence and malignant transformation and clinicopathological features.
Ishii J; Fujita K; Munemoto S; Komori T
J Clin Laser Med Surg; 2004 Feb; 22(1):27-33. PubMed ID: 15117484
[TBL] [Abstract][Full Text] [Related]
19. Oral leukoplakia classification and staging system with incorporation of differentiated dysplasia.
Brouns ER; Evren I; Wils LJ; Poell JB; Brakenhoff RH; Bloemena E; de Visscher JGAM
Oral Dis; 2023 Oct; 29(7):2667-2676. PubMed ID: 35765231
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of relationship between risk factors of malignant transformation of oral leukoplakia and the LSCP system].
Sun Z; Gong Y; Huang J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Sep; 36(5):364-6. PubMed ID: 11769652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
